GOGodwin Ogbole

Godwin Ogbole

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Godwin Ogbole has a total of 464 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Recommendations for structural magnetic resonance imaging in infants with first afebrile seizure or new onset epilepsy: Evidence‐based recommendations from the ILAE Neuroimaging Task Force

    by Gavin P. Winston, Simone Salemme, Gaetano Cantalupo, Fernando Cendes, Felice D′Arco, Paolo Federico, William D. Gaillard, Eliane Kobayashi, Edward J. Novotny, Godwin Ogbole, et al.

    Infants aged 1–24 months with new onset epilepsy frequently present with structural brain abnormalities, yet no updated evidence‐based magnetic resonance imaging (MRI) guidelines exist for this population. The International League Against Epilepsy (ILAE) Neuroimaging Task Force developed evidence‐based recommendations for structural brain MRI in infants with a first afebrile seizure or new onset epilepsy. A multidisciplinary panel defined three PICO (patients, intervention, comparison group, outcome under consideration) questions, conducted a systematic review (PROSPERO [Prospective Register of Systematic Reviews] CRD42024592653), and reported the results in line with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) 2020 guidelines. Risk of bias was evaluated using the JBI (Joanna Briggs Institute) checklist. GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology was used to assess certainty of evidence and formulate recommendations for the following: (1) the effectiveness of MRI in identifying underlying etiologies, (2) clinical predictors of MRI abnormalities, and (3) MRI protocols. Seventeen studies ( n = 1209) were included. Among 753 infants who underwent MRI, 438 (58.2%) had abnormal findings. Despite heterogeneity in MRI protocols and reporting, the evidence supports the utility of MRI in this population. Specific clinical features (focal seizure semiology, abnormal neurological examination, seizure duration > 5 min, focal electroencephalographic abnormalities, developmental delay, and perinatal complications) were associated with abnormal MRI findings, although methodological limitations reduce certainty. Only six studies provided data on MRI sequences; however, none reported findings specifically in relation to the diagnostic accuracy or yield of individual protocols, precluding the development of evidence‐based recommendations on MRI protocol selection. MRI is conditionally recommended in all infants with a first afebrile seizure or new onset epilepsy. MRI could be prioritized in those with specific clinical features indicative of higher likelihood of abnormal findings. Recommendations are based on very low certainty of evidence. These are the first ILAE‐endorsed, evidence‐based recommendations for MRI in infants with first afebrile seizure or new onset epilepsy. Further prospective studies with standardized protocols are needed to refine MRI indications and optimize diagnostic yield in this age group.


  • Influence of Ancestral and Geographic Factors on Intracerebral Hemorrhage Risks Among Africans and Americans

    by Paul Olowoyo, Osahon J. Asowata, Onoja Akpa, Mary E. Comeau, Christopher D. Anderson, Jacob L. McCauley, Joshua Akinyemi, Morenikeji Komolafe, Albert Akpalu, Oyedunni Arulogun, et al.

    BACKGROUND: We investigated whether risk factors for intracerebral hemorrhage (ICH) among indigenous Africans (IA) would vary in prevalence and effect compared with self-reported African, Hispanic, and White Americans by comparing data from 2 independent population-based case-control studies conducted in West Africa and the United States. METHODS: We compared ICH risk factors common to the SIREN (Stroke Investigative Research and Educational Network: 1100 case-control pairs) and the ERICH (Ethnic/Racial Variation of Intracerebral Hemorrhage: 999 case-control pairs African American participants, 998 case-control pairs, Hispanic Americans, 1000 case-control pairs, White Americans) studies. Ethnicity/Race was self-reported. The effect measure of interest is the odds ratio (OR). To test for differences in the effects of the risk factors between the SIREN IA study population and each of the ERICH study populations, a test for heterogeneity was computed using the R program, metagen (version 4.9-6). RESULTS: ICH occurred at a younger age among IA (54.3±13.4 years), African Americans (58.0±12.7), and Hispanic Americans (58.9±14.3), compared with White Americans (69.1±13.9). The largest distinction was for hypertension, where IA exhibited a much larger risk of ICH than the American study population (OR, 67.02 [95% CI, 33.30–134.85]), African American (OR, 3.71 [95% CI, 2.53–5.44]); Hispanic (OR, 3.55 [95% CI, 2.54–4.92]), and White population (OR, 2.69 [95% CI, 1.95–3.69]). Current alcohol use exhibited increased risk in IA (OR, 2.24 [95% CI, 1.36–3.67]), but not in African Americans (OR, 0.63 [95% CI, 0.46–0.86]), Hispanic (OR, 0.87 [95% CI, 0.65–1.17]), and White Americans (OR, 0.51 [95% CI, 0.38–0.69]). CONCLUSIONS: Identical or comparable risk factors do not consistently result in the same disease risk across different cultures and regions. Therefore, to improve our understanding of the genetic determinants and biological pathways driving ICH risk, it is crucial to study multiple populations, including IA, while accounting for the influence of environmental and social factors.


  • Open Access

    Low field, high impact: democratizing MRI for clinical and research innovation

    by Derek K Jones, Daniel C Alexander, Karen Chetcuti, Mara Cercignani, Kirsten A Donald, Mark A Griswold, Emre Kopanoglu, Ikeoluwa Lagunju, Johnes Obungoloch, Godwin Ogbole, et al.

    MRI is a cornerstone of modern clinical medicine and neuroscience, yet it remains largely inaccessible in low- and middle-income countries (LMICs) due to high costs, complex infrastructure requirements, the need for specialized personnel, and dependence on proprietary systems. Portable low-field MRI (LF-MRI), operating below 100 mT, offers a compelling alternative: low-cost, more accessible, and increasingly powerful, thanks to advances in hardware engineering, acquisition physics, image reconstruction, and open-source software. Reviewing and building upon recent progress, we, a multidisciplinary team of clinicians, physicists, engineers, and global health researchers based both in LMIC and HIC settings, present a formal argument for the adoption of LF-MRI as a catalyst for discovery science and healthcare innovation in LMICs. LF-MRI can produce clinically meaningful images and rich research data, enabling population-scale studies in neurodevelopment, ageing, and neurogenetics. But we argue that systems must be open, upgradeable, and co-developed, allowing potential for local teams to maintain, adapt, and scale technology according to their needs. Beyond the scanner, we outline the ecosystem required for success: data infrastructure, training pathways, ethical data governance, and equitable collaboration. We issue a call to researchers, vendors, and funders to reframe MRI as a globally accessible technology, capable of supporting diverse research agendas and delivering transformative health impact, particularly where it is needed most.


  • Open Access

    Challenges and Recommendations for Improving Cancer Research and Practice in Nigeria: A Qualitative Study With Multi-Stakeholders in Oncology Research and Practice

    by Mojisola M Oluwasanu, Prisca O Adejumo, Yijia Sun, Chidera Onwuka, Atara Ntekim, Olutosin A Awolude, Toyin I Aniagwu, Olayinka A Kotila, Biobele J Brown, Godwin I Ogbole, et al.

    Background: Cancers, with increasing incidence and mortality rates, constitute a leading public health problem in Nigeria. As the burden of cancer in Nigeria increases, research and quality service delivery remain critical strategies for improved cancer control across the continuum of care. This study contextualizes the challenges and gaps in oncology research and practice in Nigeria, and presents recommendations to address the gaps. Methods: This qualitative study was conducted among interprofessional and interdisciplinary stakeholders in oncology healthcare practice and research in academic settings, between July and September 2021. Key-informant interviews were held with six stakeholders and leaders in nursing, pharmacy, and medicine across the six geopolitical zones of Nigeria, and twenty-four in-depth interviews with early- or mid-career researchers or healthcare professionals involved in cancer prevention and treatment were conducted. The data were analyzed using a deductive thematic analysis approach and coded using the NVIVO 12 software. Results: Five sub-themes were identified as major challenges to oncology research, including poor funding, excessive workload, interprofessional rivalry, weak collaboration, and denial of cancer diagnosis by patients. Challenges identified for oncology practice were poor governance and financing, high costs of oncology treatments, poor public awareness of cancer, workforce shortage, and interprofessional conflicts. Recommended strategies for addressing these challenges were improved financing of oncology research and practice by government and relevant stakeholders, increasing interest of medical, nursing, and pharmaceutical students in oncology research through curricula-based approach and mentorship, increased oncology workforce, and improved intra- and inter-professional collaboration. Conclusion: These data highlight the challenges and barriers in oncology practice and research in Nigeria, and underscore the urgent need for increased investments in infrastructure to provide interdisciplinary and interprofessional research training for high-quality care. Only then can Nigeria effectively tackle the current and impending cancer burden in the country.


  • Open Access

    Determinants of First‐Ever Stroke Severity in West Africans: Evidence From the SIREN Study

    by Oladimeji Adebayo, Onoja Akpa, Osahon J. Asowata, Adekunle Fakunle, Fred S. Sarfo, Albert Akpalu, Kolawole Wahab, Reginald Obiako, Morenikeji Komolafe, Lukman Owolabi, et al.

    Background: Baseline stroke severity is probably partly responsible for poor stroke outcomes in sub‐Saharan Africa. However, there is a paucity of information on determinants of stroke severity among indigenous Africans. We sought to identify the factors associated with stroke severity among West Africans in the SIREN (Stroke Investigative Research and Educational Networks) study. Methods and Results: Stroke was diagnosed clinically and confirmed with brain neuroimaging. Severe stroke was defined as a Stroke Levity Scale score of ≤5. A multivariate logistic regression model was constructed to identify factors associated with stroke severity at 95% CI and a nominal cutoff of 5% type 1 error. A total of 3660 stroke cases were included. Overall, 50.7%% had severe stroke, including 47.6% of all ischemic strokes and 56.1% of intracerebral hemorrhage. Factors independently associated with severe stroke were meat consumption (adjusted odds ratio [aOR], 1.97 [95% CI, 1.43–2.73]), low vegetable consumption (aOR, 2.45 [95% CI, 1.93–3.12]), and lesion volume, with an aOR of 1.67 (95% CI, 1.03–2.72) for lesion volume of 10 to 30 cm 3 and aOR of 3.88 (95% CI, 1.93–7.81) for lesion volume >30 cm 3 . Severe ischemic stroke was independently associated with total anterior circulation infarction (aOR, 3.1 [95% CI, 1.5–6.9]), posterior circulation infarction (aOR, 2.2 [95% CI, 1.1–4.2]), and partial anterior circulation infarction (aOR, 2.0 [95% CI, 1.2–3.3]) compared with lacunar stroke. Increasing age (aOR, 2.6 [95% CI, 1.3–5.2]) and lesion volume >30 cm 3 (aOR, 6.2 [95% CI, 2.0–19.3]) were independently associated with severe intracerebral hemorrhage. Conclusions: Severe stroke is common among indigenous West Africans, where modifiable dietary factors are independently associated with it. These factors could be targeted to reduce the burden of severe stroke.


  • Low-field magnetic resonance image enhancement via stochastic image quality transfer

    by Hongxiang Lin, Matteo Figini, Felice D’aRco, Godwin Ogbole, Ryutaro Tanno, Stefano B. Blumberg, Lisa Ronan, Biobele J. Brown, David W. Carmichael, Ikeoluwa Lagunju, et al.


  • Open Access

    DETERMINANTS OF STROKE MORTALITY AMONG WEST AFRICANS: FINDINGS FROM THE SIREN STUDY

    by Akinkunmi Paul Okekunle, Fred Stephen Sarfo, Onoja Matthew Akpa, Osahon Jeffery Asowata, Joshua Akinyemi, Adekunle Fakunle, Godwin Ogbole, Albert Akpalu, Kolawole Wahab, Reginald Obiako, et al.


  • Open Access

    Neurocysticercosis and epilepsy: Imaging and clinical characteristics

    by Ildefonso Rodríguez‐Leyva, Karla Cantú‐Flores, Arturo Domínguez‐Frausto, Anna Elisabetta Vaudano, John Archer, Boris Bernhardt, Lorenzo Caciagli, Fernando Cendes, Yotin Chinvarun, Paolo Federico, et al.

    The ILAE Neuroimaging Task Force aimed to publish educational case reports highlighting basic aspects related to neuroimaging in epilepsy consistent with the educational mission of the ILAE. Neurocysticercosis (NCC) is highly endemic in resource‐limited countries and increasingly more often seen in non‐endemic regions due to migration. Cysts with larva of the tapeworm Taenia solium lodge in the brain and cause several neurological conditions, of which seizures are the most common. There is great heterogeneity in the clinical presentation of neurocysticercosis because cysts vary in number, larval stage, and location among patients. We here present two illustrative cases with different clinical features to highlight the varying severity of symptoms secondary to this parasitic infestation. We also present several examples of imaging characteristics of the disease at various stages, which emphasize the central role of neuroimaging in the diagnosis of neurocysticercosis.


  • Open Access

    Author Correction: Federated learning enables big data for rare cancer boundary detection

    by Sarthak Pati, Ujjwal Baid, Brandon Edwards, Micah Sheller, Shih-Han Wang, G Anthony Reina, Patrick Foley, Alexey Gruzdev, Deepthi Karkada, Christos Davatzikos, et al.